OVD in ophthalmology (Ophthalmic Viscoelastic Device) is no longer just an accessory – it has become a surgical necessity for modern anterior segment procedures, especially cataract and IOL implantation surgeries.
While the basic roles of OVDs are well-known, optimizing their use requires understanding deeper clinical value, classification, and surgical strategies.
Core Clinical Roles of OVDs (Expanded from Original)
| Function | Detailed Benefit |
|---|---|
| Endothelial protection | Reduces corneal endothelial cell loss from 10-15% to <5% when using high-quality OVD |
| Space maintenance | Prevents anterior chamber collapse during phacoemulsification and IOL insertion |
| Hemostasis & anti-adhesion | Compresses iris surface capillaries; separates blood clots & tissue fragments |
| Shock absorption | Minimizes instrument-tissue interaction |
| Wound healing | Reduces scar formation and adhesion after surgery |
OVD Classification & "Soft-Shell Technique" – A Must-Know Trend
Not all OVDs are the same. In ophthalmic surgery, OVDs fall into two main types:
| Type | Property | Best for |
|---|---|---|
| Cohesive OVD | High molecular weight (e.g., 2M+ Da), strong internal cohesion | Maintaining deep chamber, easy removal |
| Dispersive OVD | Low molecular weight, spreads thinly | Coating endothelium, protecting fragile tissues |
Modern best practice: Soft-shell technique
Inject cohesive OVD first to open the anterior chamber, then dispersive OVD to coat endothelium.
This dual approach combines clarity + protection, and is widely recommended for dense cataracts or compromised corneas.
Singclean® OVD, with its molecular weight range of 1,000,000–2,600,000 Da and 1.5% sodium hyaluronate, can be used either as a single OVD or combined in soft-shell protocols.
Clinical Evidence Supporting OVD Use in Ophthalmology
| Parameter | Without OVD | With High-Quality OVD |
|---|---|---|
| Endothelial cell loss (3 months post-op) | 12–15% | <5% |
| Intraocular pressure spike risk | Moderate (requires washout) | Low (easy removal) |
| Surgical time | Longer (more instrument entries) | Shortened by ~20% |
High-molecular-weight OVDs also reduce phaco energy use by stabilizing the chamber, indirectly protecting the corneal endothelium.
Ideal OVD Characteristics – Updated Benchmark
An ideal OVD in ophthalmology should offer:
Optical clarity – unobstructed surgical view
Space maintenance – resists collapse during phaco and IOL delivery
Endothelial protection – high dispersive coating ability
Easy removal – prevents post-op intraocular pressure elevation
Biocompatibility – non-inflammatory, non-antigenic
Non-animal origin – no risk of viral transmission or immunogenicity
Singclean® OVD meets all these criteria, with drug-grade biofermented sodium hyaluronate and CE certification for EU markets.
Why Surgeons Are Choosing Singclean® OVD
High molecular weight (1.0M–2.6M Da) for excellent chamber stability
1.5% concentration balances viscosity and removability
Phosphate-buffered saline – physiological pH, reduces post-op IOP spikes
Biofermentation-derived – no animal components, zero BSE/TSE risk
CE & ISO 13485 compliant (regulatory-ready)
Summary Table – Why OVD is Indispensable in Modern Ocular Surgery
| Surgical Step | Role of OVD |
|---|---|
| Corneal incision | Maintains chamber pressure |
| Capsulorhexis | Stabilizes anterior chamber |
| Phacoemulsification | Protects endothelium from ultrasound energy |
| IOL insertion & positioning | Prevents capsule damage |
| Aspiration & closure | Lubricates; removes debris; prevents adhesions |
Final Takeaway for Your Readers
Understanding OVD in ophthalmology means moving beyond "it's a gel" to which type, when, and how to remove it. With the right OVD – like Singclean® – ophthalmic surgeons gain safety, efficiency, and better visual outcomes.